These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11141544)

  • 1. Perceptual disturbances with zaleplon.
    Bhatia SC; Arora M; Bhatia SK
    Psychiatr Serv; 2001 Jan; 52(1):109-10. PubMed ID: 11141544
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-related illusions and hallucinations with zaleplon.
    Stone JR; Zorick TS; Tsuang J
    Clin Toxicol (Phila); 2008 Apr; 46(4):344-5. PubMed ID: 17852167
    [No Abstract]   [Full Text] [Related]  

  • 3. Zaleplon for insomnia.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):93-4. PubMed ID: 10535052
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of insomnia with zaleplon, a novel sleep medication.
    Doghramji PP
    Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NICE review: not nice for patients!
    Alford C; Verster J
    J Psychopharmacol; 2005 Mar; 19(2):129-32. PubMed ID: 15728431
    [No Abstract]   [Full Text] [Related]  

  • 6. NICE: The National Institute of Clinical Excellence -- or Eccentricity? Reflections on the Z-drugs as hypnotics.
    Nutt DJ
    J Psychopharmacol; 2005 Mar; 19(2):125-7. PubMed ID: 15728430
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)].
    Ansseau M
    Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal zaleplon abuse.
    Paparrigopoulos T; Tzavellas E; Karaiskos D; Liappas I
    Am J Psychiatry; 2008 Nov; 165(11):1489-90. PubMed ID: 18981079
    [No Abstract]   [Full Text] [Related]  

  • 9. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
    Weitzel KW; Wickman JM; Augustin SG; Strom JG
    Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of zaleplon in the treatment of insomnia.
    Israel AG; Kramer JA
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of insomnia and its therapies.
    Benca RM
    J Clin Psychiatry; 2001; 62 Suppl 10():33-8. PubMed ID: 11388589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement.
    Montplaisir J; Hawa R; Moller H; Morin C; Fortin M; Matte J; Reinish L; Shapiro CM
    Hum Psychopharmacol; 2003 Jan; 18(1):29-38. PubMed ID: 12532313
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment for insomnia.
    Schreiber V
    Lancet; 2002 Apr; 359(9315):1434; author reply 1434. PubMed ID: 11978362
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of zaleplon at peak plasma levels.
    Mangano RM
    Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
    Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Noguchi H; Kitazumi K; Mori M; Shiba T
    J Pharmacol Sci; 2004 Mar; 94(3):246-51. PubMed ID: 15037809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of zaleplon-induced amnestic sleep-related eating disorder.
    Molina SM; Joshi KG
    J Clin Psychiatry; 2010 Feb; 71(2):210-1. PubMed ID: 20193650
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
    Paul MA; Gray G; Kenny G; Pigeau RA
    Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for insomnia.
    Finucane TE
    Lancet; 2002 Apr; 359(9315):1434; author reply 1434. PubMed ID: 11978363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.